The global teledermatology market size was valued at US$ 15.4 Bn in 2024 and is expected to reach US$ 104.5 Bn by 2031, grow at a compound annual growth rate (CAGR) of 31.5% from 2024 to 2031.
Global Teledermatology Market Regional Insights:
Analyst View: The global teledermatology market shows promising growth potential over the next decade. Driven by the increasing prevalence of skin diseases and the shortage of dermatologists globally, teledermatology is expected to experience significant adoption. The cost-effective and timely diagnosis it offers for remote locations lacking specialty care can help expand dermatology access to underserved populations. However, low awareness and reluctance to adopt new technologies among some physicians and patients may hamper faster market uptake. North America likely to remain the dominant region due to higher teledermatology penetration and reimbursement coverage However, Asia Pacific is expected to offer lucrative opportunities owing to its huge patient population and growing telehealth investments in India and China. Meaningful use of block chain and AI can further supplement teledermatology by enhancing data security, automated diagnostics, and chronic disease management. Data privacy and regulatory concerns around licensing, reimbursement, and malpractice need addressing to boost provider and patient confidence. Lack of uniform telehealth legislation in some countries poses reimbursement and legal barriers as well. Integration of teledermatology within existing healthcare systems and interoperability with other digital health solutions will determine its long term scalability.
Figure 1. Global Teledermatology Market Share (%), by Region, 2024
To learn more about this report, Request sample copy
Global Teledermatology Market Drivers:
The increasing prevalence of skin diseases: The increasing prevalence of skin diseases is indeed a key factor propelling the growth of the global teledermatology market. Teledermatology, which utilizes telecommunications technologies to facilitate the exchange of medical information related to skin conditions, has become increasingly relevant in the backdrop of rising skin disease cases. Teledermatology provides broader access to specialized dermatological care, especially in remote or underserved areas where there are fewer dermatologists available. Patients benefit from being able to seek professional medical advice without the need to travel, which is particularly beneficial for those with mobility issues, those living in rural areas, or during times when travel is limited, such as public health crises. Teledermatology facilitates early detection and treatment of skin conditions by providing timely access to dermatologists, which can be critical in diseases like skin cancer. By reducing the need for in-person visits, teledermatology can decrease healthcare costs for both providers and patients, including travel expenses, indirect costs, and time savings. Teledermatology services enable primary care providers to consult with dermatologists and triage cases more effectively, ensuring that patients with more serious conditions receive expedited care. The integration of high-resolution imaging and secure digital platforms enhances the quality of remote consultations and diagnosis, contributing to the growth and acceptance of teledermatology. For instance, according to an article published by the JAMA Dermatology Journal in June 2021, the prevalence of psoriasis, an itchy skin condition in adults above the age of 20 years in the U.S., was estimated to be 3% based on the epidemiological data collected between July 2019 and December 2020. The same source estimates that around 7.55 million adults in the U.S. suffered from psoriasis in 2020.
Moreover, according to data provided by the National Psoriasis Foundation, U.S., in 2020, it is estimated that around 2% to 3% of the world’s population, or 125 million people across the globe, suffered from psoriasis in 2019.
The growing popularity of mobile health (mHealth) technology: The growing popularity of mobile health (mHealth) technology is indeed a significant factor expected to drive the global teledermatology market. mHealth refers to the use of mobile devices and wireless technology in medical care, and it offers a range of benefits that align well with the objectives and services of teledermatology. mHealth applications on smartphones and tablets make it easier for patients to access dermatological care, especially in remote and resource-limited settings where healthcare infrastructure may be lacking. mHealth apps allow users to track their skin conditions, schedule appointments, and communicate with dermatologists at their convenience, increasing patient engagement and satisfaction. With the high-quality cameras available on mobile devices, patients can capture images of their skin conditions and share them with dermatologists for analysis and recommendations, facilitating accurate remote diagnoses. The use of wearable devices that monitor various health parameters can provide valuable data to dermatologists, offering a more comprehensive picture of a patient's overall health and skin condition. mHealth solutions often reduce the need for in-person clinic visits, which can lower healthcare costs related to travel and time off work, and decrease the burden on healthcare facilities. mHealth technologies enable real-time monitoring and follow-up care for patients with chronic skin diseases, improving the management of these conditions and helping to prevent complications. mHealth apps can deliver educational content about skin health and disease prevention, raising awareness and promoting the early detection of skin conditions.
The high adoption of connected devices: The high adoption of connected devices smartphones, tablets, and various wearable technologies are key drivers propelling the global teledermatology market. Connected devices enable patients to easily access dermatological care. Individuals can consult with dermatologists via video calls, messaging, or through specialized apps, no matter where they are. With connected devices, patients have more ways to engage with their healthcare providers, manage appointments, and follow treatment plans, leading to better patient outcomes. The advanced camera technology available in most smartphones and tablets allows patients to take high-resolution images of their skin conditions to share with their dermatologists, improving the accuracy of remote diagnoses. Wearable devices that monitor health can provide real-time data to healthcare providers, offering insights into a patient's skin condition and overall health, which can be critical for managing chronic dermatological issues. Connected devices facilitate seamless teleconsultation, allowing patients to receive timely advice and second opinions from dermatologists without the need for physical travel. Many connected devices can integrate with existing healthcare systems, enabling the sharing and analysis of patient data to inform treatment decisions and streamline care.
The shortage of dermatologists: the shortage of dermatologists is one of the factors expected to drive the global teledermatology market. The lack of adequate dermatological care, especially in rural and underserved urban areas, creates a significant demand for alternative solutions to address the skin care needs of the population. Teledermatology allows dermatologists to extend their reach beyond their physical location, enabling them to serve patients in remote or underserved areas through virtual consultations. With teledermatology, patients have access to dermatological care without long wait times or the need to travel significant distances to see a specialist. Dermatologists can potentially review and diagnose more cases in less time through teledermatology as compared to traditional in-person consultations, thus optimizing available resources. Teledermatology can act as a support system for primary care providers by allowing them to consult with dermatology specialists for complex cases, improving the quality of care delivered at the primary level. Cases can be distributed among available dermatologists based on their workload and specialty, leading to more efficient use of the limited pool of specialists.
Global Teledermatology Market Opportunities:
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 15.4 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 - 2031 |
Forecast Period 2024 to 2031 CAGR: | 31.5% | 2031 Value Projection: | US$ 104.5 Bn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
Aerotel Medical Systems Ltd., MDLIVE, Visby Medical, Inc., Ksyos, VigNet Inc., Allscripts Healthcare, LLC, 3Derm, McKesson Corporation, CureSkin, Honeywell Life Care Solutions, MetaOptima, Koninklijke Philips N.V., 3Gen Consulting, AMD Global Telemedicine, GE Healthcare, First Derm |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Teledermatology Market Trends:
Global Teledermatology Market Restraints:
Recent Developments:
New product launches & Approval:
In May 2021, Google, a software development company, announced the launch of a dermatology tool powered by artificial intelligence that will help users understand issues with their skin, hair, and nails.
In April 2020, Sakhiya Skin Clinic, an India-based dermatological clinic, launched a free skin care consultation and treatment service across India via real time teledermatology, wherein the patient and the dermatologist would exchange medical information regarding the skin conditions using video conferencing. Such launches of teledermatology services help market players to address the COVID-19 pandemic as it offers contactless dermatological care solutions for patients and reduces the risk of transmission of COVID-19 via personal contact.
In March 2020, Integrated Dermatology, a U.S.-based medical and cosmetic solution provider, launched its new teledermatology virtual service to provide a real-time video consultation with a dermatologist for common skin conditions such as acne, eczema, rashes, shingles, lesions, psoriasis, cold sores, wounds, and others.
Acquisition, Collaboration, partnerships & Investment:
In May 2022, All India Institute of Medical Sciences (AIIMS) announced a collaboration with Nurithm lab, a pharmaceutical startup company, to launch an artificial intelligence-driven smartphone app named DermaAid to address access and accuracy problems in the clinical diagnosis of dermatological diseases, including skin and oral cancers. This diagnostic solution uses a machine-learning, AI-driven algorithm.
In July 2021, the National Health Service (NHS), U.K., announced an investment of US$ 27.7 million (£20 million) to support a teledermatology service wherein skin snaps of patients suspected to be suffering from skin cancer would be sent to hospitals for same-day diagnosis of skin cancer. This diagnostic teledermatology service is expected to aid in the early detection of skin cancer remotely from the patient’s home and allow for quicker treatment of skin cancer.
Figure 2. Global Teledermatology Market Share (%), by Type, 2024
To learn more about this report, Request sample copy
Top companies in Global Teledermatology Market:
Definition: Teledermatology is a subspecialty of dermatology where telecommunication technologies are used to exchange medical information regarding skin conditions and diseases. This can occur through various platforms, including but not limited to video conferencing, smartphones, the internet, and other communication tools. Its primary purpose is to provide expert skin care to patients remotely, especially those who lack direct access to dermatologists or specialized healthcare. Teledermatology encompasses a range of services such as diagnosis, treatment, education, and management of patients with skin diseases. It can involve direct interaction between the patient and the dermatologist (live interactive teledermatology) or the use of stored images and data (store-and-forward teledermatology).
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Select a License Type
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients